<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-vaccines-07-00066">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vanwalscappel</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Tada</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Landau</surname>
    <given-names>N.R.</given-names>
   </name>
  </person-group>
  <article-title>Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin</article-title>
  <source>Virology</source>
  <year>2018</year>
  <volume>522</volume>
  <fpage>199</fpage>
  <lpage>208</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virol.2018.07.014</pub-id>
  <pub-id pub-id-type="pmid">30036788</pub-id>
 </element-citation>
</ref>
